• Angiotensin (1-7): Molecular Mechanisms and Translational In

  2026-07-23

  Discover the multifaceted roles of Angiotensin (1-7) as both a Mas receptor agonist and a modulator of key signaling pathways. This article offers a deep dive into the peptide's mechanistic actions, practical assay guidance, and novel research frontiers that set it apart from prior literature.

• Reproducible Cancer Assays with Dovitinib (TKI-258, CHIR-258

  2026-07-23

  This scenario-driven article explores real laboratory challenges in cell viability and apoptosis assays, highlighting how Dovitinib (TKI-258, CHIR-258) (SKU A2168) delivers reproducible, quantitative results for RTK-driven cancer research. Researchers gain actionable insights into protocol optimization, data interpretation, and reliable sourcing, all underpinned by literature and validated workflow recommendations.

• Taxus chinensis Fruit Extract Inhibits Neuroinflammation via

  2026-07-22

  This study demonstrates that Taxus chinensis fruit extract (TCFE) attenuates aging-related behavioral and neuroinflammatory changes in mice by inhibiting microglial activation through the TLR4/NF-κB/NLRP3 pathway. These findings clarify a molecular mechanism for natural anti-inflammatory action, informing future research on neuroinflammation, aging, and the translational use of TLR4 inhibitors.

• Triamcinolone: Protocols and QC for Glucocorticoid Research

  2026-07-22

  Triamcinolone (SKU B1859) is a synthetic glucocorticoid agonist designed for in vitro studies of glucocorticoid signaling, inflammation, and immunosuppression. It addresses the need for controlled, high-purity reagents in cellular assays but is not intended for clinical or diagnostic use.

• M344: Precision HDAC Inhibition for Translational Neuroblast

  2026-07-21

  This thought-leadership article explores the mechanistic underpinnings and translational promise of M344, a potent histone deacetylase inhibitor (HDACi), in pediatric cancer research—particularly neuroblastoma. By blending mechanistic insight, comparative analysis, and protocol guidance, it positions M344 as a uniquely powerful tool for researchers seeking next-generation epigenetic interventions. The article draws on recent in vitro and in vivo studies, highlights workflow optimization, and offers a forward-looking perspective relevant to preclinical and translational teams.

• HyperFluor™ 594 Goat Anti-Rabbit IgG Antibody: Workflow Mast

  2026-07-21

  The HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody empowers researchers with unparalleled specificity and photostability for multiplexed immunodetection. Its robust fluorophore enables high-sensitivity workflows in ICC, IHC, and flow cytometry, streamlining troubleshooting and experimental optimization for advanced translational research.

• A-1210477: Defining MCL-1 Dependency in Cancer Cell Survival

  2026-07-20

  Explore how the MCL-1 inhibitor A-1210477 enables precise dissection of apoptosis regulation in cancer cells. This article delivers advanced insights on functional MCL-1 dependency, practical assay guidance, and the translational significance for cancer research.

• Precision Signal Amplification: Cy5 TSA Kit in Hepatobiliary

  2026-07-20

  Explore how the Cy5 TSA Fluorescence System Kit delivers superior sensitivity for immunohistochemistry and in situ hybridization, enabling precise detection of low-abundance targets. This article uniquely bridges advanced amplification chemistry with cutting-edge applications in liver cell fate research.

• Baricitinib (LY3009104): Deep Dive into JAK-STAT Immune Modu

  2026-07-19

  Explore how Baricitinib (LY3009104) precisely modulates JAK-STAT pathways, focusing on its role in dissecting IL-6/STAT3 signaling and immune crosstalk. This article uniquely applies spatial proteomics findings to practical assay design and preclinical inflammation models.

• Bacitracin (B1670): Practical Protocols for Antibacterial Re

  2026-07-18

  Bacitracin (B1670) is a peptide antibiotic formulated for controlled laboratory research targeting bacterial cell wall and peptidoglycan synthesis. It is not intended for diagnostic or medical use, and strict adherence to storage and handling protocols is essential for reproducibility.

• Guidelines for Diagnosing and Treating Mucocutaneous Candidi

  2026-07-17

  This article reviews the 2009 clinical guidelines for mucocutaneous candidiasis, detailing diagnostic strategies, disease subtypes, and treatment protocols. The study emphasizes the efficacy of imidazole antifungal agents, such as Neticonazole Hydrochloride, as first-line topical therapies for cutaneous candidiasis, and discusses both the clinical rationale and practical workflow for laboratory and translational researchers.

• AI-Driven Discovery of Novel Senolytics: Methods and Insight

  2026-07-17

  The reference study pioneered a machine learning-based approach for identifying new senolytic compounds, significantly reducing the cost and scale needed for initial drug discovery. Its findings demonstrate the feasibility of computationally guided senolytic screening, providing a foundation for future translational research in cellular senescence and cancer.

• Pravastatin Sodium: Applied HMG-CoA Reductase Inhibitor Work

  2026-07-16

  Leverage Pravastatin sodium for high-fidelity cholesterol biosynthesis inhibition and advanced cell-based modeling. This guide spotlights experimental protocols, troubleshooting strategies, and critical innovations that set APExBIO’s offering apart for both cardiovascular and translational research.

• Sodium Ascorbate in Glioblastoma Workflows: Protocols & Inno

  2026-07-16

  Sodium Ascorbate, a mineral salt of ascorbic acid, enables precise modeling of ROS-driven necrotic tumor cell death and microenvironment modulation in glioblastoma and other cancer research. This guide details optimized protocols, troubleshooting insights, and the translational innovations that set Sodium Ascorbate apart for advanced oncology workflows.

• Baricitinib (LY3009104): Precision JAK1/2 Inhibition in Tran

  2026-07-15

  This article provides a thought-leadership perspective on Baricitinib (LY3009104) as a highly selective JAK1/2 inhibitor, bridging mechanistic insight with strategic guidance for translational researchers. By integrating recent spatial proteomics findings on IL-6/PD-L1 crosstalk in primary sclerosing cholangitis and highlighting best-in-class protocol parameters, we demonstrate how Baricitinib can accelerate immune modulation studies beyond current product literature.

17086 records 1/1140 page Next 12345 下5页 Last page